MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.32
+0.01 (+0.76%)
As of Jun 30, 10:36 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,059.1% upside
Low Target $17.57
Average Target $28.50
High Target $41.49
Current Price $1.32
Current
$1.32
Target
$28.50
$17.57 $28.50 avg $41.49
Scenario Analysis
Bear Case
$17.57
1,231.1%
Low target
Base Case
$28.50
+2,059.1%
Avg target
Bull Case
$41.49
+3,043.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$1.96
-32.7% from high
52-Week Low
$1.17
+13.0% from low
Target vs 52W High
$28.50
+1,354.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%